- Filed
- Feb 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 6, 2025 | 10.77M sh |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $1.81M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $1.48M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $170.55K |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $226.84K |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $270.55K |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $277.34K |
| Current Assets | Q2 2025 · Dec 31, 2024 | $360.97K |
| Current Assets | Q2 2025 · Jun 30, 2024 | $44.21K |
| Total Assets | Q2 2025 · Dec 31, 2024 | $2.12M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $1.8M |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 10.44M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 10.35M sh |
| Capex | Q2 2025 · Dec 31, 2023 | $0 |
| Operating Cash Flow restated | Q2 2025 · Dec 31, 2023 | −$1.8M |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$0.05 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$0.06 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | −$0.05 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | −$0.06 |
| Sga Expense restated | Q2 2025 · Dec 31, 2023 | $501.61K |
| Sga Expense restated | Q2 2025 · Dec 31, 2023 | $635.13K |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $0 |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $0 |
| Net Income restated | Q2 2025 · Dec 31, 2023 | −$499.41K |
| Net Income restated | Q2 2025 · Dec 31, 2023 | −$633.06K |
| Operating Income restated | Q2 2025 · Dec 31, 2023 | −$501.61K |
| Operating Income restated | Q2 2025 · Dec 31, 2023 | −$635.13K |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $0 |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $0 |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $0 |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $0 |
| Revenue | Q2 2025 · Dec 31, 2023 | $0 |
| Revenue | Q2 2025 · Dec 31, 2023 | $0 |